Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2005 May 17;19(3):93–98. doi: 10.1002/jcla.20060

Interleukin‐4 gene, but not the interleukin‐1 beta gene polymorphism, is associated with oral cancer

Ming‐Hsui Tsai 1, Wen‐Chi Chen 2,3, Chang‐Hai Tsai 4, Liang‐Wen Hang 5, Fuu‐Jen Tsai 2,6,✉
PMCID: PMC6807771  PMID: 15900573

Abstract

We aimed to evaluate whether polymorphisms of the interleukin‐4 (IL‐4) gene promoter and intron 3 regions, and polymorphisms of the IL‐1 beta gene promoter and exon 5 regions are associated with oral cancer. This study included 130 patients with oral cancer and 105 age‐matched healthy controls who lived in the same area as the patients. Each genetic polymorphism was typed by polymerase chain reaction (PCR)‐based restriction analysis. We then compared the genotype distribution and allelic frequencies of each polymorphism between the oral cancer patients and the controls. The CC homozygote genotype of the IL‐4 gene promoter −590 region differed significantly between the patients with oral cancer and the controls (odds ratio (OR)=6.0, 95% confidence interval (CI)=1.2−30.7, chi‐square test, P=0.044). No significant difference in either the genotype distribution or the allelic frequencies of the IL‐1 beta gene polymorphisms was observed between patients with oral cancer and controls. The IL‐4 gene −590 C/T polymorphism is associated with oral cancer and is a suitable genetic marker for screening for oral cancer. However, whether the −590 C/T polymorphism of the IL4 gene plays a role in oral cancer remains unclear. Further substantiation based on larger patient samples is needed. J. Clin. Lab. Anal. 19:93–98, 2005. © 2005 Wiley‐Liss, Inc.

Keywords: IL‐1 gene polymorphism, IL4 gene polymorphism, oral cancer

REFERENCES

  • 1. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking, and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995;24:450–453. [DOI] [PubMed] [Google Scholar]
  • 2. Jayant K, Balakrishnan V, Sanghvi LD, Jussawala DJ. Quantification of the role of smoking and chewing habits in oral, pharynx, and esophageal cancer. Br J Cancer 1977;35:232–235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Cheng YA, Tsai CC. Nicotine‐ and arecoline‐induced interleukin‐1 secretion and intercellular adhesion molecular‐1 expression in human oral epidermoid carcinoma cells in vitro. Arch Oral Biol 1999;44:843–851. [DOI] [PubMed] [Google Scholar]
  • 4. Jeng JH, Kuo ML, Hahn LJ, Kuo MYP. Genotoxic and non‐genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res 1994;73:1043–1049. [DOI] [PubMed] [Google Scholar]
  • 5. Yamamoto T, Yoneda K, Ueta E, Hirota J, Osaki T. Serum cytokine levels in patients with oral mucous membrane disorders. J Oral Pathol Med 1991;20:275–279. [DOI] [PubMed] [Google Scholar]
  • 6. Tsai CC, Chen CC, Lin CC, Chen CH, Lin TS, Shieh TY. Interleukin‐1 beta in oral submucous fibrosis, mucous hyperplasia and squamous cell carcinoma tissues. Kaohsiung J Med Sci 1999;15:513–519. [PubMed] [Google Scholar]
  • 7. Mehrotra R, Varricchio F, Husain SR, Puri RK. Head and neck cancers, but not benign lesions, express interleukin‐4 receptors in situ. Oncol Rep 1998;5:45–48. [DOI] [PubMed] [Google Scholar]
  • 8. Sosroseno W, Herminajeng E, Goeno S. The interleukin network in the immunopathogenesis of oral diseases. Asian Pac J Allergy Immunol 1994;12:161–168. [PubMed] [Google Scholar]
  • 9. Das BR, Nagpal JK. Understanding the biology of oral cancer. Med Sci Monit 2002;8:258–267. [PubMed] [Google Scholar]
  • 10. Nagpal JK, Patnaik S, Das BR. Prevalence of high‐risk human papilloma virus types and its association with p53 codon‐72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of eastern India. Int J Cancer 2002;97:649–653. [DOI] [PubMed] [Google Scholar]
  • 11. Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human IL‐1 receptor antagonist gene (IL1RN) maps to chromosome 2q14‐q21, in the region of the IL‐1alpha and IL‐1beta loci. Genomics 1992;13:654–657. [DOI] [PubMed] [Google Scholar]
  • 12. Cantagrel A, Navaux F, Loubet‐Lescoulie P, et al. Interleukin‐1beta, interleukin‐1 receptor antagonist, interleukin‐4, and interleukin‐10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093–1100. [DOI] [PubMed] [Google Scholar]
  • 13. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86‐base pair repeat polymorphism in the interleukin‐1‐receptor antagonist gene but not with polymorphisms in the interleukin‐1beta gene. J Bone Miner Res 2000;15:402–414. [DOI] [PubMed] [Google Scholar]
  • 14. Chandler SW, Rassekh CH, Rodman SM, Ducatman BS. Immunohistochemical localization of interleukin‐10 in human oral and pharyngeal carcinomas. Laryngoscope 2002;112:808–815. [DOI] [PubMed] [Google Scholar]
  • 15. Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin‐6 and interleukin‐6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002;24:850–858. [DOI] [PubMed] [Google Scholar]
  • 16. Jablonska E, Piotrowski L, Grabowska Z. Serum levels of IL‐1b,IL‐6, TNFa, sTNF‐RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997;3:126–129. [DOI] [PubMed] [Google Scholar]
  • 17. Rosenwasser LJ, Klemm DJ, Dresback JK, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995;2(S):74–78. [DOI] [PubMed] [Google Scholar]
  • 18. Le Beau MM, Lemons RS, Espinosa R, Larson RA, Arai N, Rowley JD. Interleukin‐4 and interleukin‐5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del (5q). Blood 1989;73:647–650. [PubMed] [Google Scholar]
  • 19. Mout R, Willemzze R, Landegent JE. Repeat polymorphisms in the interleukin‐4 gene. Nucleic Acids Res 1991;19:3763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Rosenwasser LJ, Borish L. Genetics of atopy and asthma: the rationale behind promoter‐based candidate gene studies (IL‐4 and IL‐10). Am J Respir Crit Care Med 1997;156:S152–S155. [DOI] [PubMed] [Google Scholar]
  • 21. Noguchi E, Shibasaki M, Arinami T, et al. Evidence for linkage between asthma/atopy in childhood and chromosome 5q31‐q33 in a Japanese population. Am J Respir Crit Care Med 1997;156:1390–1393. [DOI] [PubMed] [Google Scholar]
  • 22. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002;68:617–621. [PubMed] [Google Scholar]
  • 23. Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC. Cytotoxic and genotoxic effects of areca nut‐related compounds in cultured human buccal epithelial cells. Cancer Res 1989;49:5294–5298. [PubMed] [Google Scholar]
  • 24. Hsu HJ, Chang KL, Yang YH, Shieh TY. The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases. Kaoshiung J Med Sci 2001;17:175–182. [PubMed] [Google Scholar]
  • 25. Chang YC, Hu CC, Tseng TH, Tai KW, Li CK, Chou MY. Synergistic effects of nicotine on arecholine‐induced cytoxicity in human bucosal fibroblasts. J Oral Pathol Med 2001;30:458–464. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES